Literature DB >> 11040035

Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.

I Ishii1, J J Contos, N Fukushima, J Chun.   

Abstract

Lysophosphatidic acid (LPA) is a potent lipid mediator with diverse physiological actions on a wide variety of cells and tissues. Three cognate G-protein-coupled receptors have been identified as mammalian LPA receptors: LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7. The mouse forms of these genes were analyzed in rodent cell lines derived from nervous system cells that can express these receptors functionally. An efficient retrovirus expression system was used, and each receptor was heterologously expressed in B103 rat neuroblastoma cells that neither express these receptors nor respond to LPA in all assays tested. Comparative analyses of signaling pathways that are activated within minutes of ligand delivery were carried out. LPA induced cell rounding in LP(A1)- and LP(A2)-expressing cells. By contrast, LP(A3) expression resulted in neurite elongation in B103 cells and inhibited LPA-dependent cell rounding in TR mouse neuroblast cells that endogenously express LP(A1) and LP(A2) but not LP(A3). Each of the receptors could couple to multiple G-proteins and induced LPA-dependent inositol phosphate production, mitogen-activated protein kinase activation, and arachidonic acid release while inhibiting forskolin-induced cAMP accumulation, although the efficacy and potency of LPA varied from receptor to receptor. These results indicate both shared and distinct functions among the three mammalian LPA receptors. The retroviruses developed in this study should provide tools for addressing these functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040035     DOI: 10.1124/mol.58.5.895

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  54 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.

Authors:  Sung Hee Hwang; Tae-Joon Shin; Sun-Hye Choi; Hee-Jung Cho; Byung-Hwan Lee; Mi Kyung Pyo; Jun-Ho Lee; Jiyeon Kang; Hyeon-Joong Kim; Chan-Woo Park; Ho-Chul Shin; Seung-Yeol Nah
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

3.  Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells.

Authors:  Jiro Sakai; Masahiro Oike; Masakazu Hirakawa; Yushi Ito
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

4.  Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

Authors:  Xianjun Fang; Shuangxing Yu; Janos L Tanyi; Yiling Lu; James R Woodgett; Gordon B Mills
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.

Authors:  Jun Xu; Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

6.  The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Authors:  Wenlin Deng; E Shuyu; Ryoko Tsukahara; William J Valentine; Gangadhar Durgam; Veeresa Gududuru; Louisa Balazs; Venkatraman Manickam; Marcello Arsura; Lester VanMiddlesworth; Leonard R Johnson; Abby L Parrill; Duane D Miller; Gabor Tigyi
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

Review 7.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

8.  NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.

Authors:  Yong-Seok Oh; Nam Won Jo; Jung Woong Choi; Hyeon Soo Kim; Sang-Won Seo; Kyung-Ok Kang; Jong-Ik Hwang; Kyun Heo; Sun-Hee Kim; Yun-Hee Kim; In-Hoo Kim; Jae Ho Kim; Yoshiko Banno; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.

Authors:  Keisuke Yanagida; Kayo Masago; Hiroki Nakanishi; Yasuyuki Kihara; Fumie Hamano; Yoko Tajima; Ryo Taguchi; Takao Shimizu; Satoshi Ishii
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

10.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.